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Cutaneous Squamous Cell 
Carcinoma: A Smoking Gun  
but Still No Suspects
John T. Schiller1 and Christopher B. Buck1
A viral etiology for cutaneous squamous cell carcinoma (cuSCC) has long 
been suspected, primarily on the basis of its dramatically increased incidence 
in immunocompromised individuals. In this issue, Arron and colleagues 
report a comprehensive hunt for viral gene transcription in cuSCC. Their find-
ings show that it is very unlikely that any currently known virus is commonly 
responsible for the maintenance of this cancer.
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Identification of a viral cause of a 
human cancer is desirable because 
it provides unique opportunities for 
intervention, particularly prevention. 
This is well illustrated by the recently 
introduced prophylactic vaccine to 
prevent infection by the sexually trans-
mitted human papillomavirus (HPV) 
types most frequently associated 
with cervical and other anogeni-
tal and oral cancers. A common 
“smoking gun” trait of cancers with 
a well-documented viral etiology is 
their increased incidence in immuno-
compromised individuals (Grulich et 
al., 2007). This is presumably attrib-
utable to impaired immunological 
control over what might otherwise be 
a harmless infection. Risk of nonmela-
noma skin cancer, including cutane-
ous squamous cell carcinoma (cuSCC), 
is dramatically increased after immu-
nosuppression, with a more than 
50-fold increase in incidence among 
recipients of solid-organ transplants. It 
has therefore long been suspected that 
cuSCC may be caused by an infectious 
agent. Significant attention has been 
focused on cutaneous HPVs, particu-
larly those from papillomavirus genus-
b (b-HPV), because they ubiquitously 
and chronically infect the skin and are 
clearly implicated in skin carcinogen-
esis in a rare genodermatosis known 
as epidermodysplasia verruciformis 
(Feltkamp et al., 2008).
The conclusion that the association 
of mucosatropic HPVs with anogeni-
tal cancers is causal is supported by 
many lines of laboratory and epide-
miological evidence. The consistent 
maintenance of the viral genome, as 
well as ongoing transcription of the 
viral oncogenes in essentially every 
cell of the tumor, is a central compo-
nent of this causal inference. To date, 
the evidence suggesting a causal role 
for cutaneous HPVs in cuSCC in the 
general population has been mixed, at 
best (Nindl et al., 2007). b-HPV DNA 
is frequently detected in cuSCC, and 
some studies have detected higher 
serological responses to b-HPV virions 
in cases than in controls. However, 
viral DNA is also frequently detected 
in normal skin and, in studies that 
have evaluated viral genome copy 
number in cuSCC tumor specimens, 
this number was usually much less 
than one viral genome per tumor cell. 
Because these studies used HPV DNA 
and serological assays designed to 
evaluate only a few of the many doz-
ens of known HPV species, they left 
open the possibility that an unstudied 
subset of HPV types not targeted by 
the assays was more strongly associ-
ated with cuSCC.
In this issue, Arron and colleagues 
report their use of the powerful new 
technology of high-throughput mRNA 
sequencing to provide an unbiased 
and comprehensive assessment of 
the causal role of HPV gene expres-
sion in cuSCC. Using random prim-
ers, they amplified and sequenced 
a representative fraction of the total 
transcriptosome from 31 cuSCC and 
8 patient-paired normal skin biop-
sies, with an impressive mean count 
of 3.5 million reads per sample. The 
sequence reads, averaging 54 nucleo-
tides in length, were compared with a 
database of all known viruses. Only 
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one SCC showed evidence of HPV 
transcripts (HPV92, a b-HPV) and 
only at very low levels (0.0001% of 
total reads). In important controls for 
the technical aspects of the study, 
HPV16 transcripts were detected rela-
tively abundantly in a cervical SCC 
and a periungual SCC positive for 
HPV16 DNA (0.02% and 0.06% of 
total reads, respectively). Transcripts 
of other eukaryotic virus were not 
detected with any substantial fre-
quency. Therefore, the results strongly 
support the important conclusion that 
known virus species are not consistent 
contributors to the maintenance of 
cuSCCs.
The study leaves open the possibil-
ity that a virus may be involved in the 
initiation, but not the maintenance, of 
cuSCCs. Because b-HPVs are known 
to encode candidate oncoproteins that 
interfere with proapoptotic signaling 
in epithelial cells, they might prevent 
UV-induced apoptosis, thereby allow-
ing keratinocytes with UV-induced 
mutations to survive and progress to 
carcinomas (Jackson et al., 2000). 
Although this type of hit-and-run 
mechanism is often dismissed, it has 
been clearly documented in experi-
mental systems. In the most relevant 
example, bovine papillomavirus type 
4 (BPV4) induces alimentary tract 
papil lomas that can progress to cancer 
in experimentally challenged cattle. 
Although the initial papillomatous pre-
cursor lesions contain BPV4 DNA, the 
malignant carcinomas are devoid of the 
viral DNA (Campo et al., 1994). If this 
mechanism were to function in cuSCC, 
it would imply that there is strong bio-
logical or immunological selection for 
loss of viral gene expression during 
carcinogenic progression. It is unclear 
why this would be the case for cutane-
ous, but not genital, neoplasia.
Unfortunately, compelling evidence 
for hit-and-run etiology is difficult to 
obtain in clinical studies. Establishing 
such a connection would probably 
require the unequivocal identifica-
tion of the critical cuSCC precursor 
lesion and the demonstration that the 
precursor usually contained nucleic 
acid sequences of a particular virus 
or group of viruses. Serological stud-
ies might also be useful for the estab-
lishment of hit-and-run etiologies 
because antibody responses are often 
very durable and can serve as a fos-
sil record of infection, even if the 
malignant lesion does not ultimately 
contain nucleic acid sequences of 
the etiologically responsible patho-
gen. Unfortunately, serological inves-
tigations have the drawback that they 
require individual study of known viral 
serotypes. Furthermore, serological 
results could reflect indirect effects. 
For example, the increased serologi-
cal responsiveness of cuSCC patients 
against b-HPVs could theoretically 
reflect a generalized loss of immuno-
logical control over multiple types of 
viral infections, including HPVs, and 
an unknown pathogen that is the true 
culprit underlying cuSCC.
The work by Arron and colleagues 
(2011) also leaves open the possibility 
that cuSCC is caused by an as-yet 
unknown virus with too little similar-
ity to known viruses to be detected in 
BLAST homology searches. Interesting 
new human skin viruses continue to 
be identified, as exemplified by four 
recently discovered cutaneous poly-
omaviruses—Merkel cell polyoma-
virus (Feng et al., 2008), HPyV6 and 
HPyV7 (Schowalter et al., 2010), and 
tricho dysplasia spinulosa-associated 
polyomavirus (van der Meijden et al., 
2010)—and a number of recently iden-
tified cutaneous HPVs (particularly 
of the highly diverse papillomavirus 
genus-g; Kohler et al., 2011). It is likely 
that the explosive increase in the use 
of high-throughput sequencing tech-
nologies will uncover additional new 
cutaneous viruses, perhaps some from 
currently unknown virus families. 
An attractive aspect of Arron and col-
leagues’ work is that it provides a 
large, valuable, and publically accessi-
ble data set (deposited in the National 
Center for Biotechnology Information 
Sequence Read Archive) that includes 
more than 1 million unidentified tran-
script reads with no clear homology 
to known human sequences. These 
unknown reads could be a useful hunt-
ing ground for future studies aimed 
at establishing possible associations 
between newly discovered viral iso-
lates and the maintenance of cuSCC. In 
other words, the fact that the usual viral 
suspects previously hypothesized to 
underlie cuSCC have not been caught 
at the crime scene should not be taken 
to mean that the case is closed.
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|It is unlikely that a known virus is responsible for 
maintenance of cuSCC.
